Results 161 to 170 of about 2,326,154 (344)
Does Systemic Risk in the Financial Sector Predict Future Economic Downturns?
Linda Allen, Turan G. Bali, Yi Tang
openalex +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Systemic risk contagion of green and Islamic markets with conventional markets. [PDF]
Naeem MA, Karim S, Yarovaya L, Lucey BM.
europepmc +1 more source
Cascading Defaults and Systemic Risk of a Banking System
Jin‐Chuan Duan, Changhao Zhang
openalex +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Hedge funds and systemic risk. [PDF]
A hedge fund is a privately offered investment vehicle that pools the contributions of investors in order to invest in a variety of assets, such as securities, futures, options, bonds and currencies.
Ferguson, R., Laster, D.
core
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Systemic risk prevention policies targeting systemically important banks: Does clustering pattern matter? [PDF]
Zhu B, Hu X, Deng Y, Lin R.
europepmc +1 more source
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Dynamic Banking Systemic Risk Accumulation under Multiple-Risk Exposures. [PDF]
Fan H, Tang M.
europepmc +1 more source

